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Abstract
Background: The Seveso, Italy accident in 1976 caused the contamination of a large population
by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Possible long-term effects have been examined
through mortality and cancer incidence studies. We have updated the cancer incidence study which
now covers the period 1977-96.
Methods: The study population includes subjects resident at the time of the accident in three
contaminated zones with decreasing TCDD soil levels (zone A, very high; zone B, high; zone R,
low) and in a surrounding non-contaminated reference territory. Gender-, age-, and period-
adjusted rate ratios (RR) and 95% confidence intervals (95% CI) were calculated by using Poisson
regression for subjects aged 0-74 years.
Results: All cancer incidence did not differ from expectations in any of the contaminated zones.
An excess of lymphatic and hematopoietic tissue neoplasms was observed in zones A (four cases;
RR, 1.39; 95% CI, 0.52-3.71) and B (29 cases; RR, 1.56; 95% CI, 1.07-2.27) consistent with the
findings of the concurrent mortality study. An increased risk of breast cancer was detected in zone
A females after 15 years since the accident (five cases, RR, 2.57; 95% CI, 1.07-6.20). No cases of
soft tissue sarcomas occurred in the most exposed zones (A and B, 1.17 expected). No cancer
cases were observed among subjects diagnosed with chloracne early after the accident.
Conclusion: The extension of the Seveso cancer incidence study confirmed an excess risk of
lymphatic and hematopoietic tissue neoplasms in the most exposed zones. No clear pattern by time
since the accident and zones was evident partly because of the low number of cases. The elevated
risk of breast cancer in zone A females after 15 years since the accident deserves further and
thorough investigation. The follow-up is continuing in order to cover the long time period (even
decades) usually elapsing from exposure to carcinogenic chemicals and disease occurrence.
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2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the most
toxic congener in the family of polychlorinated dibenzo-
dioxins, PCDD, is a nearly ubiquitous contaminant of the
environment in which we live [1]. Potential health effects
of TCDD have been investigated in high exposure circum-
stances such as, for example, manufacture and agricultural
use, war, and industrial/environmental accidents. The
International Agency for Research on Cancer and the US
Environmental Protection Agency (EPA), classified TCDD
as human carcinogen [2,3]; still the scientific debate per-
sists on the actual cancer risk posed by TCDD to the gen-
eral population [4-7]. The industrial accident that
occurred in the Seveso, Italy area on July 10, 1976 exposed
a large residential population to substantial amounts of
TCDD. In the immediate aftermath, typical effects of
exposure to polychlorinated hydrocarbons such as chlo-
racne were observed mainly in children who were out-
doors at the time the accident occurred [8]. A variety of
other early and mid-term health effects were then investi-
gated including reproductive, immunologic, metabolic
changes with no clear indications of adverse outcomes
[9]. Long term effects were investigated by means of mor-
tality and cancer incidence studies [10]. The clearest and
most consistent result in the mortality study after 25 years
(1976-2001) was an excess of lymphatic and hematopoi-
etic neoplasms in the most exposed groups living in zones
A and B [11]. We report here the results of the five-year
extension (1992-1996) of the cancer incidence study now
covering the period 1977-1996. The cancer incidence
study, although limited to a shorter follow-up period in
comparison to the mortality study, has the clear advan-
tages to use more accurate cancer diagnoses based on clin-
ical data collection and to allow earlier detection of low
lethality cancers.
Methods
Methods used to identify the study population, exposure
definition, follow-up and case ascertainment were previ-
ously described in detail [12] and are here briefly summa-
rized.
Exposure
The area where the toxic cloud released by a chemical fac-
tory deposited was subdivided into three zones based on
measurements of TCDD soil levels [13]: Zone A (the most
heavily contaminated), zone B (medium exposure) and
zone R (low exposure); a surrounding non-contaminated
territory including 11 municipalities was adopted as refer-
ence (figure 1).
Only ten years later, improvements in analytical tech-
niques allowed to measure individual TCDD levels in the
very small blood samples collected at the time of the acci-
dent from subjects chosen as the supposedly most
exposed in zone A, B and R [14] and properly stored.
Additional measurements were then performed in 110
subjects randomly selected from zone A and B and the
non-contaminated reference zone in the early nineties
[15]. As shown in Table 1, the zone-based classification of
exposure was in fair agreement with blood TCDD meas-
urements. The serum levels of six other PCDDs, 10
PCDFs, and four coplanar PCBs were also measured in
these subjects [15]. We calculated total TEQ (Toxic Equiv-
alency, the sum of congener-specific TEQs) using WHO-
2005 TEFs (Toxic Equivalency Factors) [16]. In the con-
taminated zones none of the 20 congeners was above
background values [15]. In particular: octa-chloro dioxin
and furan (OCDD, OCDF) showed some variation across
zone (p = 0.09 and p = 0.03, respectively; Kruskal-Wallis
test), but their levels were lower than in the reference
zone; for all the other congeners p-values were above
0.14. Total TEQ was clearly elevated in the polluted zones,
whereas when we excluded TCDD from TEQ calculation
no differences were found across zones (Table 1).
Map of the Seveso, Italy area, including the territory of 11 townsFigure 1
Map of the Seveso, Italy area, including the territory 
of 11 towns. The map indicates the three dioxin-contami-
nated zones with decreasing mean soil levels (A, B, and R) 
and the surrounding non-contaminated zone adopted as the 
reference.Page 2 of 11
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was estimated equal to 7.8 years with a longer half-life in
women (nine years) than in men (seven years) [14].
Shorter half-lives in younger subjects (less than 18 years)
[17] and in highly exposed adults [18] have been recently
calculated. This would imply lower cumulative exposures
in subjects with elevated TCDD concentrations.
Living in the area after the exposure mitigation and recla-
mation works did not seem to entail additional exposure:
in a small sample of subjects entering zone B in the post-
accident period serum TCDD levels were undetectable; in
addition, sequential serum TCDD measurements in sub-
jects residing in zone B at the time of the accident did not
show increasing levels over time [14].
Study population
The Seveso cohort includes all subjects living in one of the
contaminated or reference zones at the date of the acci-
dent (July 10, 1976) and those who migrated into (or
newborn in) the area in the 10-year period after the acci-
dent. Subjects were assigned to one of the contaminated
or reference zones on the basis of their residence at the
date of the accident or at entry into the area. About 80%
of the cohort subjects were resident in the study area at the
day the accident occurred. Table 2 reports their distribu-
tion by area and gender. The results reported here refer to
the experience of the subgroup of subjects, aged 0-74
years, and living in the study area at the accident time.
Follow-up and case ascertainment
The study population (exposed and non-exposed) has
been followed up for mortality and cancer incidence as a
unique cohort, with the same methods, blinded of the
exposure status. Persons who moved outside the study
area were nonetheless traced with a higher than 99% suc-
cess rate [11].
Cancer cases ascertainment encompassed the 120 hospi-
tal-network of the Lombardy region where the study area
is located. It is the most populated region of Italy
(9,032,554 people out of 56,995,744 in the whole coun-
try at 2001 census). About 95% of the population was still
residing within the region at the end of 1996. For case
ascertainment, the complete information on all hospital
admission/discharge forms (anonymous) in the Lom-
Table 1: TCDD soil measurements, serum TCDD and TEQ levels in residents in the Seveso area.
Zone Mean soil
TCDD
(μg/m2)a
Serum TCDD
(ppt)
Serum TEQb
(ppt)
Serum TEQb
without TCDD
(ppt)
Min - Max No.
Subjects
Median Median (Min - Max) Median (Min - Max)
A 15.5 - 580.4 296 447.0c - -
7 73.3d 94.0 (60.6 - 141.7) 39.0 (16.7 - 51.8)
B 1.7 - 4.3 80 94.0c - -
51 12.4d 43.2 (17.7 - 194.3) 31.8 (11.4 - 131.7)
R 0.9 - 1.4 48 48.0c NA NA
Reference NA 52 5.5d 38.8 (10.2 - 92.1) 32.3 (8.2 - 82.4)
p < 0.0001e p = 0.92e
NA, not available
aReference [13]
bCalculated using TEF WHO-2005 [16]; includes seven dioxins, 10 furans, four coplanar PCBs.
Levels below detection limit (DL) were set to DL/√2
cBlood samples collected in 1976 (reference [14])
dBlood samples collected in 1993-94 (reference [15])
eKruskal-Wallis test
Table 2: Number of subjects resident at the accident time (July 
10, 1976) in the Seveso area.
Zone Females Males Total
A 371 352 723
B 2,350 2,471 4,821
R 15,928 15,715 31,643
Reference 93,225 88,349 181,574
Total 111,874 106,887 218,761Page 3 of 11
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records of cohort members using data on gender, date of
birth and residence. This allowed the identification of the
potential study subjects admitted in or discharged by a
Lombardy hospital with a diagnosis mentioning cancer.
Original medical records were then reexamined to iden-
tify true cases, to retrieve a diagnosis as accurate as possi-
ble and the actual date of occurrence. The number of
individual medical files identified in the period 1992-
1996 was 36,589 and 99.9% of them were successfully
reviewed. In the absence of a region-wide cancer registra-
tion system, case ascertainment had to be performed indi-
vidually, on medical papers, by ad hoc trained researchers.
The study covered malignant tumours at any site, plus
benign tumours of liver, bladder and central nervous sys-
tem first diagnosed after the date of the accident. Cancer
sites and morphology were coded using the International
Classification of Diseases in use at the time of cancer
occurrence and the International Classification of Dis-
eases for Oncology (ICD-O) respectively.
Emigration was homogeneous across zones. The propor-
tions of subjects who moved outside Lombardy were
5.8%, 6.7%, 4.7% for the exposed zones (A, B, R) and
5.6% for the reference zone. For subjects without hospital-
ization and people emigrated outside Lombardy cancer
cases were identified solely from death certificates (Death
Certificate Only, DCO).
Statistical analysis
Rate ratios (RR) and 95% confidence intervals (95% CI)
for zones A, B, R vs the reference zone were calculated
using Poisson regression models adjusting by gender, age
category, and period (five-year classes). Analysis by time
since the date of the accident was also performed (0-4, 5-
9, 10-14, 15+ years). The subgroup of subjects with a pre-
vious diagnosis of chloracne was separately examined.
Only malignant tumours have been examined. All statisti-
cal analyses were performed using Stata, version 10 [19].
Results
The total number of cases detected in the zones affected by
dioxin contamination (A, B and R) was 2,122 and 660
(31.1%) occurred after 1991. The proportion of cases
diagnosed through death certificate only (DCO) in the
whole period was 7.2% and did not vary across zones. The
overall histology confirmation rate over the study period
is 82% with a slightly higher proportion in zone B (87%).
Incidence findings for specific cancer sites are reported in
Table 3 by exposure zone. Overall, cancer incidence did
not depart from expectations.
In zone A, sparse increased risks were found for multiple
sites (skin, bladder, brain), however based on a very small
number of cases. Seven lung cancer cases yielded a 10%
increased risk; all cases were in males (RR, 1.25; 95% CI,
0.6-2.6). A 40% non-significant increase of breast cancer
and a higher than two-fold non-significantly increased
risk for uterus cancer were observed among females. One
of the breast cancers was detected in a male (0.05 were
expected). A moderate, non-significantly increased RR
was also observed for neoplasms of the lymphohemopoi-
etic tissues. In an attempt to distinguish pre- and post-
menopausal cases of breast cancer, a separate analysis for
cancer diagnosed before and after 50 years of age was
done: the RRs were 1.50 (three cases, 95% CI, 0.48-4.67)
and 1.39 (five cases, 95% CI, 0.58-3.36), respectively. All
cases occurred in women aged 20-49 years at the time of
the accident (RR, 1.98; 95% CI, 0.99-3.96).
In zone B, a 78% excess risk was found for rectal cancer.
The excess was limited to males (13 cases; RR, 2.1; 95%
CI, 1.2-3.7). A higher than two-fold increased risk was
observed for cancers of the biliary tract. Of the six cases,
four occurred among females yielding a RR of 3.1 (95%
CI, 1.1-8.6). The excess risk was already present in the 15
years post accident analysis (1977-1991) and no addi-
tional cases were detected in this extended follow-up 10.
Among respiratory cancers a three-fold significant
increase was seen for pleural cancer, particularly among
males (three cases; RR, 3.89; 95% CI, 1.19-12.7). Lym-
phohemopoietic neoplasms showed as a single category a
56% excess with borderline statistical significance. Multi-
ple myeloma and myeloid leukaemia occurrence was
clearly in excess.
Modest, non-significant increases were observed in zone R
for esophageal cancer, testis cancer and Hodgkin's disease.
No cases of soft tissue sarcoma (ICD-9: 171) occurred in
zone A and B (1.17 expected), whereas nine cases were
observed in zone R yielding a 30% non-significant excess:
seven cases occurred among males (RR, 2.1; 95% CI, 0.9-
5.1) and two among females (RR, 0.6; 95% CI, 0.1-2.4).
When also sarcomas of parenchymal organs were added,
no increased risks were detected in any of the exposed
zones (zone A: no cases; zone B: three cases and zone R:
24 cases).
Table 4 shows results of the analysis by time since the acci-
dent, for selected cancer causes.
In zone A, all cancers showed a slightly increased risk after
15 years. A similar pattern was observed for lung cancer,
lymphohemopoietic neoplasms and breast cancer (signif-
icant after 15 years). In zone B, no definite time-related
patterns were seen for all cancers and lung cancer. The
most notable finding was the excess for lymphohemopoi-
etic neoplasms observed in the 0-4 and 10-14 years cate-Page 4 of 11
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Cancer sites (ICD-9 code) Zone A (high exposure) Zone B (medium exposure) Zone R (low exposure)
N RR 95% CI N RR 95% CI N RR 95% CI
All cancers (140-208) 44 1.03 0.76-1.38 270 1.00 0.89-1.13 1808 0.96 0.91-1.00
Digestive (150-159) 7 0.59 0.28-1.23 79 1.06 0.85-1.33 495 0.94 0.85-1.03
Esophagus (150) 0 - - 1 0.26 0.04-1.91 35 1.33 0.92-1.92
Stomach (151) 3 0.86 0.28-2.69 19 0.87 0.55-1.37 131 0.84 0.70-1.01
Colon (153) 2 0.68 0.17-2.72 19 1.04 0.66-1.64 137 1.04 0.87-1.26
Rectum (154) 0 - - 17 1.78 1.09-2.88 71 1.05 0.82-1.35
Liver (155) 0 - - 14 1.29 0.76-2.20 56 0.74 0.56-0.97
Biliary tract (156) 0 - - 6 2.28 1.00-5.17 16 0.82 0.49-1.39
Pancreas (157) 1 1.15 0.16-8.19 3 0.56 0.18-1.74 38 0.99 0.70-1.40
Other digestive (159) 1 6.96 0.96-50.6 0 - - 3 0.46 0.14-1.48
Respiratory (160-165) 7 0.88 0.42-1.85 48 0.98 0.73-1.30 350 1.02 0.91-1.15
Lung (162) 7 1.12 0.53-2.36 37 0.96 0.69-1.33 280 1.04 0.92-1.19
Pleura (163) 0 - - 4 3.38 1.22-9.37 5 0.60 0.24-1.50
Soft tissue sarcoma (171) 0 - - 0 - - 9 1.32 0.64-2.73
Soft tissue and visceral sarcomas 0 - - 3 0.82 0.26-2.58 24 0.98 0.64-1.51
Melanoma (172) 1 1.62 0.23-11.61 2 0.50 0.12-2.03 19 0.71 0.44-1.14
Skin (173) 3 1.39 0.45-4.32 5 0.37 0.15-0.90 88 0.93 0.75-1.17
Breast (174) 8 1.43 0.71-2.87 30 0.85 0.59-1.22 249 1.00 0.88-1.15
Genito-urinary tract (179-189) 8 1.07 0.53-2.14 46 0.98 0.73-1.31 302 0.91 0.81-1.03
Uterus (179-182) 4 2.34 0.87-6.27 10 0.93 0.49-1.73 61 0.79 0.60-1.03
Cervix (180) 2 2.67 0.66-10.77 7 1.47 0.69-3.12 28 0.84 0.57-1.25
Endometrium (182) 1 1.24 0.17-8.82 3 0.60 0.19-1.87 27 0.73 0.49-1.10
Ovary (183) 1 1.11 0.16-7.90 1 0.18 0.02-1.25 45 1.12 0.82-1.54
Prostate (185) 0 - - 7 0.94 0.45-1.99 39 0.75 0.54-1.05
Testis (186) 0 - - 2 0.82 0.20-3.32 22 1.44 0.90-2.31
Bladder (188) 3 1.44 0.46-4.49 17 1.33 0.82-2.16 84 0.94 0.75-1.19Page 5 of 11
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cases, RR, 1.92; 95% CI, 0.98-3.75 respectively). Steadily
increased risks for multiple myeloma were observed in
each category within 15 years since the accident.
In zone R, a numerical increase of the RR values with time
since initial exposure was observed: however, none of the
values was significantly above unity with the exception of
multiple myeloma after 15 years since the accident.
No other distinct patterns or trends were seen for other
specific cancer causes (results not shown).
No cancer cases were observed among the group of people
(n = 183) who were diagnosed as chloracne cases shortly
after the accident. It's important to mention that subjects
with chloracne were very young at the time of the accident
(their mean age was 10 years). The age standardized
number of expected cancer cases was 1.7.
Discussion
The follow-up of the population affected by the Seveso
accident in 1976 had the primary goal to identify possible
late occurring consequences of exposure to TCDD on
health. It also represented a unique opportunity to
improve our present knowledge on the carcinogenic haz-
ard posed by TCDD to human populations. In fact, both
environmental [20] and biological data (serum TEQ with-
out TCDD were similar across zones, as reported in Table
1) showed that TCDD was the only congener to which
people in Seveso were exposed.
In animal models, TCDD is a multisite carcinogen that
induces cancer in different organs, species and strains.
Increased incidence of lymphomas, fibrosarcomas and
neoplasms of liver, lung, thyroid, skin, tongue, hard pal-
ate and nasal turbinates have been found [21]. TCDD is
generally characterized as a non-genotoxic carcinogen, a
potent promoter and a weak initiator. Several potential
mechanisms for carcinogenicity have been implicated
including oxidative stress, indirect DNA damage, endo-
crine disruption, altered signal transduction and cell rep-
lication leading to tumour promotion [22]. The human
epidemiologic evidence mainly relies on four industrial
cohorts [23-26] with high exposures which showed a con-
sistent increase in all cancers combined with a positive
exposure-response trend. In interpreting these results, we
need to consider recent studies which applied new models
to estimate exposure in these cohorts and raised questions
on the potential overestimate of the dose-response rela-
tionship [18,27]. Increased risks for some distinct cancer
sites (lung, Non-Hodgkin's Lymphoma, soft tissue sar-
coma) have also been reported but their specific associa-
tion with TCDD exposure is less compelling [2].
Kidney (189) 0 - - 6 0.87 0.39-1.96 43 0.90 0.65-1.24
Brain (191) 2 2.43 0.60-9.79 4 0.76 0.28-2.045 37 1.04 0.73-1.48
Thyroid (193) 1 2.63 0.37-18.86 4 1.60 0.59-4.36 19 1.15 0.70-1.89
Lymphatic and hematopoietic tissue
(200-208)
4 1.39 0.52-3.71 29 1.56 1.07-2.27 121 0.96 0.79-1.16
All lymphoma (200-202) 1 0.62 0.09-4.41 15 1.43 0.86-2.40 72 1.02 0.80-1.32
Hodgkin's disease (201) 0 - - 3 1.20 0.38-3.78 23 1.46 0.91-2.29
Non-Hodgkin's lymphoma (200, 202) 1 0.80 0.11-5.69 12 1.51 0.85-2.69 49 0.90 0.66-1.22
Multiple myeloma (203) 1 2.88 0.40-20.70 6 2.77 1.2-6.32 18 1.15 0.70-1.91
Leukemia (204-208) 2 2.18 0.54-8.76 8 1.35 0.66-2.73 31 0.77 0.53-2.12
Lymphatic leukemia (204) 1 2.78 0.39-19.9 0 - - 13 0.83 0.46-1.48
Myeloid leukemia (205) 1 2.23 0.31-15.99 7 2.41 1.12-5.18 15 0.76 0.44-1.30
Leukemia, unspecified (208) 0 - - 1 2.16 0.29-16.10 2 0.61 0.14-2.60
*Subjects aged < 75 years, resident in the area at the accident time.
ICD-9: International Classification of Diseases, Ninth Revision; N: number of cases; RR: rate ratios calculated with Poisson regression, adjusted for 
gender, age category, and period; 95% CI: 95% confidence interval.
Table 3: Results of cancer incidence analyses in the Seveso population*, 1977-96. (Continued)Page 6 of 11
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Environmental Health 2009, 8:39 http://www.ehjournal.net/content/8/1/39Table 4: Results of cancer incidence analyses in the Seveso population*, 1977-96, by time since the accident.
Cancer sites Zone Years since the accident
0-4 5-9 10-14 15 +
All cancers A N 8 8 9 19
RR 1.06 0.84 0.83 1.27
95% CI 0.53-2.12 0.42-1.68 0.43-1.60 0.81-2.00
B N 55 51 72 92
RR 1.13 0.84 1.05 1.02
95% CI 0.87-1.48 0.63-1.10 0.83-1.32 0.83-1.26
R N 339 411 455 603
RR 0.94 0.93 0.96 0.99
95% CI 0.84-1.06 0.84-1.03 0.87-1.06 0.90-1.07
Lung cancer A N 1 1 1 4
RR 0.84 0.73 0.57 2.04
95% CI 0.12-5.96 0.10-5.19 0.08-4.08 0.76-5.47
B N 8 8 9 12
RR 1.02 0.89 0.86 1.09
95% CI 0.50-2.05 0.44-1.79 0.44-1.66 0.61-1.93
R N 37 70 83 90
RR 0.66 1.09 1.15 1.20
95% CI 0.47-0.92 0.84-1.41 0.91-1.46 0.95-1.50
Lymphatic and hematopoietic tissue cancer A N - - 1 3
RR 1.39 2.96
95% CI 0.20-9.96 0.95-9.22
B N 9 5 9 6
RR 2.39 1.33 1.92 0.95
95% CI 1.22-4.69 0.55-3.25 0.98-3.75 0.42-2.12
R N 20 27 32 42
RR 0.75 1.03 1.01 1.00
95% CI 0.47-1.20 0.68-1.55 0.70-1.48 0.72-1.38
Non-Hodgkin's lymphoma A N - - - 1
RR 1.97
95% CI 0.27-14.07
B N 2 2 5 3
RR 1.75 1.37 2.30 0.94
95% CI 0.43-7.20 0.34-5.62 0.93-5.66 0.30-2.96
R N 5 15 8 21
RR 0.61 1.44 0.54 0.99
95% CI 0.24-1.53 0.82-2.53 0.26-1.12 0.62-1.58
Leukemia A N - - 1 1
RR 5.11 3.26
95% CI 0.71-37.07 0.45-23.44
B N 3 1 2 2
RR 1.90 0.85 1.55 1.05
95% CI 0.60-6.05 0.12-6.15 0.38-6.37 0.26-4.29Page 7 of 11
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nature, might be affected by several sources of bias. Some
can be addressed in the design and conduct phases of the
study, and some can only be indirectly addressed.
Throughout the follow-up period, all tracing and case
ascertainment procedures were implemented concur-
rently, with the same methods, and blinded of the expo-
sure status of the subject for both the index and the
reference population. Tracing for hospital admissions was
conducted within the Lombardy region where 95% of the
study population was still residing at the end of the fol-
low-up. Emigration rates outside Lombardy were low and
similar across zones, thus minimizing the possible bias
due to exposure related selective migration. A definite lim-
itation of our study is the exposure categorization which
was based on environmental contamination data (TCDD
soil measurements) and the official residence of the sub-
jects at the time of the accident. In the absence of individ-
ual exposure data, misclassification of exposure might
have occurred since the level of exposure inside each zone
was not homogeneous and could vary considerably;
moreover, official residence does not necessarily coincide
with actual presence in the area at the time of the accident.
Any such misclassification should be non-differential
with risk estimates biased towards the null. Importantly,
the extent of such possible misclassification is attenuated
by further pieces of information available. Later TCDD
blood measurements, although in limited samples, lent
credibility to the existing zone categorization (A very high,
B high, R low and scanty) and also showed that in the ref-
erence zone people exposure levels were similar to the
published background values [15]. Also, data collected
through questionnaire in cross-sectional studies in the
area showed that official residence is highly concordant
with presence in the area at the time of the accident [15].
The index and reference populations are included within
the same health district and share major macro and
micro-environmental factors - including health services,
referral physicians, life style, industrial and occupational
features, diet and leisure. This close comparability pro-
vides fair assurance of an indirect control of other major,
relevant and possibly confounding risk factors.
The study confirmed the excess of lymphatic and hemat-
opoietic neoplasms although without a clear pattern
across zones of decreasing average exposure. The finding
is consistent with the results of the concurrent mortality
study [11] where, in addition, an exposure related risk pat-
tern was visible. The small number of events and the lack
of individual exposure metrics may have affected the
R N 6 8 14 3
RR 0.55 0.98 1.60 0.24
95% CI 0.24-1.26 0.46-2.07 0.88-2.90 0.07-0.75
Multiple myeloma A N - - - 1
RR 8.35
95% CI 1.14-61.31
B N 2 2 2 -
RR 3.56 4.76 4.47
95% CI 0.85-15.00 1.11-20.38 1.04-19.20
R N 1 2 4 11
RR 0.23 0.63 1.28 2.24
95% CI 0.03-1.70 0.15-2.68 0.44-3.77 1.11-4.49
Breast cancer (females only) A N - 1 2 5
RR 0.81 1.42 2.57
95% CI 0.11-5.74 0.35-5.68 1.07-6.20
B N 4 6 10 10
RR 0.70 0.79 1.09 0.78
95% CI 0.26-1.87 0.35-1.76 0.58-2.04 0.42-1.46
R N 48 59 55 87
RR 1.10 1.07 0.87 1.01
95% CI 0.81-1.49 0.81-1.41 0.66-1.15 0.81-1.27
*Subjects aged < 75 years, resident in the area at the accident time.
ICD-9: International Classification of Diseases, Ninth Revision; N: number of cases; RR: rate ratios calculated with Poisson regression, adjusted for 
gender and age category; 95% CI: 95% confidence interval.
Table 4: Results of cancer incidence analyses in the Seveso population*, 1977-96, by time since the accident. (Continued)Page 8 of 11
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the small yet highly polluted zone A particularly after 15
years since the accident, whereas in zone B the risk was
high in the early post-accident period. The increase is con-
sistent with the findings of occupational cohort studies
[23-25,28] and with experimental data [21]. In addition,
a cohort of Finnish fishermen with dioxin concentrations
comparable to those found in the Seveso population,
showed a 28% non-statically significant increased mortal-
ity from lymphatic and hematopoietic neoplasms [29].
Comparisons by specific lymphohemopoietic neoplasms
across studies are made difficult by the small number of
events.
The slightly increased risk for breast cancer in zone A
females became significant after 15 years since the acci-
dent, based on five cases. No such increase was detected in
zone B. This finding is consistent with the Seveso
Women's Health Study that showed a dose response rela-
tionship between breast cancer and serum TCDD levels in
the highly exposed women resident in zone A and B at the
time of the accident after adjusting for other major risk
factors such as parity, lactation, age at first pregnancy,
smoking, etc [30]. Industrial cohorts were mainly com-
prised of men; the most updated mortality of the IARC
international cohorts showed a twofold increased risk for
breast cancer among female workers exposed to TCDD or
higher chlorinated dioxins [28]. The increase was
restricted to the only cohort with a consistent portion of
female workers [31]. A mortality study conducted in Rus-
sia reported a two-fold increased risk of breast cancer
among women living in Chapaevsk, an area contaminated
by dioxin by a chemical plant producing exachlorocy-
cloexane and its derivatives [32]. In addition, although
limited by the ecological nature of the study, a spatial cor-
relation between increased breast cancer incidence and
soil dioxin contamination in a few areas in Michigan,
USA, has been described [33]. TCDD is known to have
some anti-estrogenic effects, however accumulating evi-
dence suggests that TCDD also possesses estrogen-like
activities. In particular, it has been suggested that the anti-
estrogenic effects in the presence of estrogen and the estro-
genic effects in its absence may alter the effects of TCDD
depending on life stage at exposure [34]. All women with
breast cancer in zone A were exposed to the accident
between 20-49 years and the risk did not differ for pre-
and post-menopausal cancers.
In interpreting the results for gynecological tumors,
chance cannot be excluded as a credible explanation of
the noted increase. Few studies on TCDD exposed females
exist, and the extension of the follow-up will probably
provide some further clues for interpretation.
Among people living in zone A, a twofold increased,
although statistically non-significant, risk for lung cancer
(in males) was estimated, after a 15-year latency period.
The concurrent and most extended mortality follow-up
had already shown in this zone a 60-70% increased risk
after 15 years of follow-up [11]. Slightly increased mortal-
ity from lung cancer has been found in the four most
exposed industrial cohorts, particularly in highly exposed
subjects, but when dose-response relationships were
examined, some uncertainty remained about the nature of
the association with TCDD exposure [23-26,35,36]. Con-
founding by smoking has been evaluated in most of these
studies and could not entirely explain the observed excess.
We did only indirectly control for smoking habits in this
study, based on information collected from limited sam-
ples and on the documented social and cultural homoge-
neity of the groups compared in this study [37].
Soft tissue sarcomas have been repeatedly associated to
dioxin exposure [2]. In our population no cases were
observed in the most exposed zones (1.17 were expected).
A modest non-significant increased risk was detected
among males in the least exposed zone R. Overall our data
provide us with poor evidence of the association between
dioxin exposure and soft tissue sarcoma in agreement
with a recent case-control study which failed to show an
increased risk at comparable exposure levels [38].
The increased risk for biliary tract cancer among females
in zone B was already present in the 15 year analysis. No
new cases have been detected after 1991.
Two further distinctly increased risks in zone B should be
considered. The rectal cancer increase we observed among
males has not been clearly associated to TCDD exposure
in other epidemiologic studies and is not supported by
experimental data. The increase of pleural cancer occur-
rence is probably due to asbestos exposure well docu-
mented in two chemical plants located in the study area.
The absence of cancer cases among chloracne subjects can
be explained in terms of small population size and youth
of the subjects at the time of the accident.
Conclusion
The Seveso population constitutes a unique opportunity
to evaluate the carcinogenic risk posed by TCDD (the
main congener to which the population was exposed).
The five-year (1992-1996) extension of the cancer inci-
dence study confirmed an excess risk of lymphatic and
hematopoietic neoplasms in the most exposed popula-
tion groups although no consistent pattern by time since
the accident was evident. An elevated risk of breast cancer
was noted in zone A after 15 years since the accident and
it deserves further and thorough investigation. The follow-Page 9 of 11
(page number not for citation purposes)
Environmental Health 2009, 8:39 http://www.ehjournal.net/content/8/1/39up is continuing in order to cover the long time period
(even decades) usually elapsing between exposure to car-
cinogenic chemicals and disease occurrence. Overall, our
findings support the evaluation that TCDD represents a
carcinogenic hazard to exposed people, at least at the lev-
els experienced by this population after an industrial acci-
dent.
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